Related Experiment Video
Updated: Oct 12, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Association Between Heart Failure With Preserved Left Ventricular Ejection Fraction and Impaired Left Atrial Phasic
Rui Shi1, Ke Shi1, Shan Huang1
1Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Insights
Left atrial (LA) phasic function is significantly impaired in hypertrophic cardiomyopathy (HCM) patients with heart failure with preserved ejection fraction (HFpEF). This impairment is independent of left ventricular (LV) global longitudinal strain.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Biomedical Engineering
Background:
- Heart failure (HF) in hypertrophic cardiomyopathy (HCM) often presents as preserved left ventricular (LV) ejection fraction (HFpEF).
- The specific role of left atrial (LA) phasic function in the development of HFpEF within HCM patients remains unclear.
Purpose of the Study:
- To investigate the association between LA phasic function and HFpEF in HCM patients.
- To utilize cardiac magnetic resonance imaging (MRI) feature tracking for this assessment.
Main Methods:
- Retrospective study of 154 HCM patients, categorized into HFpEF and non-HF groups.
- Cardiac MRI with feature tracking to evaluate LA reservoir, conduit, and booster pump functions, alongside LV global longitudinal strain (GLS).
- Statistical analyses included regression and reclassification models to determine independent associations.
Main Results:
- No significant difference in LV GLS was observed between HFpEF and non-HF groups.
- Patients with HFpEF exhibited significantly impaired LA reservoir, conduit, and booster pump strain.
- LA reservoir and booster pump strain were independently associated with HFpEF and improved reclassification models.
Conclusions:
- Left atrial phasic function is severely compromised in HCM patients with HFpEF.
- LA function, particularly reservoir and booster pump function, plays a critical role in HFpEF in HCM, independent of LV function.
Background:
The majority of heart failure (HF) in hypertrophic cardiomyopathy (HCM) manifests as a phenotype with preserved left ventricular (LV) ejection fraction; however, the exact contribution of left atrial (LA) phasic function to HF with preserved ejection fraction (HFpEF) in HCM remains unresolved.
Purpose:
To define the association between LA function and HFpEF in HCM patients using cardiac magnetic resonance imaging (MRI) feature tracking.
Study Type:
Retrospective.
Population:
One hundred and fifty-four HCM patients (HFpEF vs. non-HF: 55 [34 females] vs. 99 [43 females]).
Field Strength/Sequence:
3.0 T/balanced steady-state free precession.
Assessment:
LA reservoir function (reservoir strain [εs ], total ejection fraction [EF]), conduit function (conduit strain [εe ], passive EF), booster-pump function (booster strain [εa ] and active EF), LA volume index, and LV global longitudinal strain (LV GLS) were evaluated in HCM patients.
Statistical Tests:
Chi-square test, Student's t-test, Mann-Whitney U test, multivariate linear regression, logistic regression, and net reclassification analysis were used. Two-sided P < 0.05 was considered statistically significant.
Results:
No significant difference was found in LV GLS between the non-HF and HFpEF group (-10.67 ± 3.14% vs. -10.14 ± 4.01%, P = 0.397), whereas the HFpEF group had more severely impaired LA phasic strain (εs : 27.40 [22.60, 35.80] vs. 18.15 [11.98, 25.90]; εe : 13.80 [9.20, 18.90] vs. 7.95 [4.30, 14.35]; εa : 13.50 [9.90, 17.10] vs. 7.90 [5.40, 14.15]). LA total EF (37.91 [29.54, 47.94] vs. 47.49 [39.18, 55.01]), passive EF (14.70 [7.41, 21.49] vs. 18.07 [9.32, 24.78]), and active EF (27.19 [17.79, 36.60] vs. 36.64 [26.63, 42.71]) were all significantly decreased in HFpEF patients compared with non-HF patients. LA reservoir (β = 0.90 [0.85, 0.96]), conduit (β = 0.93 [0.87, 0.99]), and booster (β = 0.86 [0.78, 0.95]) strain were independently associated with HFpEF in HCM patients. The model including reservoir strain (Net Reclassification Index [NRI]: 0.260) or booster strain (NRI: 0.325) improved the reclassification of HFpEF based on LV GLS and minimum left atrial volume index (LAVImin ).
Data Conclusion:
LA phasic function was severely impaired in HCM patients with HFpEF, whereas LV function was not further impaired compared with non-HF patients.
Level Of Evidence:
4 TECHNICAL EFFICACY: Stage 3.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure
Mitral Stenosis II: Clinical features and Diagnostic Tests
Heart Failure II: Pathophysiology
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction

